Hjem › Psoriasis › Californien
Psoriasis kliniske forsøg i Californien
13 studier for Psoriasis søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, Fountain Valley
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07013201A Study to Assess Deucravacitinib Safety in Pregnancy
- University of California San Diego, La Jolla
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Kvinder · Opdateret 1. okt. 2026 · NCT07017699Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Fremont
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 22. sep. 2026 · NCT07362017The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07487831A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- og 1 flere
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Local Institution - 0025, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Dermatology Research Associates, Los Angeles
- og 3 flere
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 3. sep. 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50176, Fremont
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT07219420The Effects of Audio-Based Therapy on Anxiety in Psoriasis
- Liao Lab at UCSF, San Francisco
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 23. jul. 2026 · NCT07390487A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Chula Vista
- Study Center, Fountain Valley
- Study Center, Fremont
- og 3 flere
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 9. jul. 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
- University of California, Davis - Dermatology Department, Sacramento
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 16. jun. 2026 · NCT06574178Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Kinetic Clinical Research, Anaheim
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 7. aug. 2025 · NCT06846710Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
RekruttererObservationsstudie
Alle aldre · Kvinder · Opdateret 28. jan. 2025 · NCT02103361Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.